HK1114556A1 - External skin agent comprising modified clay for preventing inflammation - Google Patents

External skin agent comprising modified clay for preventing inflammation

Info

Publication number
HK1114556A1
HK1114556A1 HK08104460.5A HK08104460A HK1114556A1 HK 1114556 A1 HK1114556 A1 HK 1114556A1 HK 08104460 A HK08104460 A HK 08104460A HK 1114556 A1 HK1114556 A1 HK 1114556A1
Authority
HK
Hong Kong
Prior art keywords
external skin
modified clay
skin agent
preventing inflammation
skin
Prior art date
Application number
HK08104460.5A
Other languages
English (en)
Inventor
Yasuhiro Ohara
Masashi Suzuki
Norikazu Takano
Shunpei Mitsuyama
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of HK1114556A1 publication Critical patent/HK1114556A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
HK08104460.5A 2004-12-22 2008-04-22 External skin agent comprising modified clay for preventing inflammation HK1114556A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004371895 2004-12-22
PCT/JP2005/022139 WO2006067945A1 (fr) 2004-12-22 2005-11-25 Agent cutane externe comprenant de l'argile modifiee utile en prevention de l'inflammation

Publications (1)

Publication Number Publication Date
HK1114556A1 true HK1114556A1 (en) 2008-11-07

Family

ID=35999539

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08104460.5A HK1114556A1 (en) 2004-12-22 2008-04-22 External skin agent comprising modified clay for preventing inflammation

Country Status (12)

Country Link
US (2) US8741323B2 (fr)
EP (1) EP1846010B1 (fr)
JP (1) JP5044402B2 (fr)
KR (1) KR101228862B1 (fr)
CN (1) CN101084000B (fr)
AT (1) ATE518543T1 (fr)
AU (2) AU2005317496B2 (fr)
CA (1) CA2592068C (fr)
ES (2) ES2371026T3 (fr)
HK (1) HK1114556A1 (fr)
TW (1) TWI422393B (fr)
WO (1) WO2006067945A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2371026T3 (es) * 2001-10-19 2011-12-26 Atritech, Inc. Dispositivo de oclusión ajustable en la orejuela auricular izquierda.
JP5718568B2 (ja) * 2006-06-27 2015-05-13 テクサス、エンテラソーベンツ、インク アルミノケイ酸カルシウム薬
JP5695289B2 (ja) * 2007-08-02 2015-04-01 ポーラ化成工業株式会社 乳化剤形の皮膚外用剤
CA2750559A1 (fr) * 2009-02-05 2010-08-12 Digna Biotech, S.L. Formulations pharmaceutiques de peptides inhibiteurs de tgf-.beta.1
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
JP5165736B2 (ja) * 2010-08-06 2013-03-21 株式会社シャネル化粧品技術開発研究所 トラネキサム酸エステルの生理学的に許容される塩を含む外用組成物の製造方法
US8956664B2 (en) 2011-10-20 2015-02-17 Salient Pharmaceuticals Incorporated Methods and compositions for treating mucositis
KR102245069B1 (ko) 2011-12-19 2021-04-26 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
CN104983604A (zh) * 2015-06-30 2015-10-21 江苏奇力康皮肤药业有限公司 去油保湿洁面乳及其制备方法
CA3023148A1 (fr) * 2016-05-09 2017-11-16 Nanoegg Research Laboratories, Inc. Composition pour le traitement ou la prevention de la dermatite atopique
EP3897530A1 (fr) 2018-12-21 2021-10-27 Unilever IP Holdings B.V. Compositions antimicrobiennes comprenant de l'argile modifiée et des copolymères triblocs non ioniques
KR102077047B1 (ko) * 2019-08-09 2020-02-14 한국지질자원연구원 벤토나이트를 유효성분으로 포함하는 화장료 조성물
CN115589946A (zh) * 2022-10-18 2023-01-13 安赛搏（重庆）生物技术有限公司（Cn） 一种沙漠蔷薇叶愈伤组织提取物的制备方法及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0047804A1 (fr) * 1980-09-15 1982-03-24 Unilever Plc Emulsions eau-dans-huile et procédé pour leur préparation
JPS61113646A (ja) * 1984-11-08 1986-05-31 Shiseido Co Ltd シリコンオイルを含むゲル組成物
JPS61114721A (ja) * 1984-11-08 1986-06-02 Shiseido Co Ltd 乳化剤組成物
JPS61129033A (ja) 1984-11-28 1986-06-17 Shiseido Co Ltd 乳化剤組成物
JPS61212321A (ja) * 1985-03-15 1986-09-20 Shiseido Co Ltd 乳化剤組成物
JPS6254759A (ja) * 1985-09-03 1987-03-10 Shiseido Co Ltd シリコンオイルを含むゲル組成物
JPS62216635A (ja) * 1986-03-18 1987-09-24 Shiseido Co Ltd 油中水および多価アルコ−ル型乳化組成物
US5036108A (en) * 1988-12-14 1991-07-30 Kao Corporation Water-in-oil emulsion cosmetic
AU6974191A (en) * 1989-12-20 1991-07-18 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
JPH0570336A (ja) * 1991-09-13 1993-03-23 Kose Corp 油中水型乳化化粧料
JPH08217695A (ja) 1995-02-10 1996-08-27 Pola Chem Ind Inc 皮膚外用剤
CN1103585C (zh) * 1995-03-14 2003-03-26 普罗克特和甘保尔公司 分散的蒙脱石粘土作为水包油稳定剂用于洁肤液体组合物
AU1593697A (en) 1996-01-23 1997-08-20 Chemisch Adviesbureau Drs J.C.P.Schreuder B.V. Composition for treating skin affections and process for its preparation
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6148264A (en) * 1998-07-06 2000-11-14 Exxonmobil Upstream Research Company Method for removing seismic noise caused by external activity
CO5150167A1 (es) * 1998-12-04 2002-04-29 Johnson & Johnson Consumer Composiciones para el cuidado de la piel, que contienen sales de cinc y retinoides
KR100371491B1 (ko) 1999-07-27 2003-02-07 주식회사 두산 피부 보호용 크림조성물
US6855342B2 (en) 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
JP2002047129A (ja) * 2000-08-02 2002-02-12 Kose Corp 乳化化粧料
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
US6923975B2 (en) * 2001-05-17 2005-08-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method of enhanced moisture or reduced drying using wet-skin treatment compositions
JP2003026608A (ja) * 2001-07-10 2003-01-29 Nof Corp 皮膚外用剤組成物
JP2003026529A (ja) 2001-07-12 2003-01-29 Kose Corp 油性化粧料
JP4936618B2 (ja) 2001-09-21 2012-05-23 株式会社ノエビア 微細エマルション組成物
FR2830195B1 (fr) 2001-10-03 2004-10-22 Sederma Sa Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
ES2371026T3 (es) * 2001-10-19 2011-12-26 Atritech, Inc. Dispositivo de oclusión ajustable en la orejuela auricular izquierda.
JP2003160462A (ja) * 2001-11-21 2003-06-03 Pola Chem Ind Inc バリアー機能を有する機能性皮膚外用剤
JP2003192525A (ja) * 2001-12-27 2003-07-09 Pola Chem Ind Inc 疑似生体性ポリマー及びスフィンゴシン類似物質を含有する皮膚外用剤
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
JP4024189B2 (ja) * 2003-07-17 2007-12-19 ポーラ化成工業株式会社 保湿用の化粧料
DE602004011092T2 (de) 2003-10-21 2009-01-02 Unilever N.V. Haarkonditionierungszusammensetzungen
JP4090054B2 (ja) * 2004-01-14 2008-05-28 株式会社資生堂 皮膚外用医薬製剤

Also Published As

Publication number Publication date
ES2371027T3 (es) 2011-12-26
TWI422393B (zh) 2014-01-11
US20150306118A9 (en) 2015-10-29
ATE518543T1 (de) 2011-08-15
CA2592068A1 (fr) 2006-06-29
AU2011200366B2 (en) 2011-10-13
US20100003210A1 (en) 2010-01-07
KR20070092296A (ko) 2007-09-12
TW200637584A (en) 2006-11-01
JP5044402B2 (ja) 2012-10-10
US20150051170A2 (en) 2015-02-19
AU2011200366A1 (en) 2011-02-17
CN101084000B (zh) 2011-11-16
JP2008524115A (ja) 2008-07-10
AU2005317496B2 (en) 2010-10-28
ES2371026T3 (es) 2011-12-26
US20140235577A1 (en) 2014-08-21
KR101228862B1 (ko) 2013-02-05
WO2006067945A1 (fr) 2006-06-29
US8741323B2 (en) 2014-06-03
AU2005317496A1 (en) 2006-06-29
CA2592068C (fr) 2015-01-13
CN101084000A (zh) 2007-12-05
EP1846010B1 (fr) 2011-08-03
EP1846010A1 (fr) 2007-10-24

Similar Documents

Publication Publication Date Title
HK1114556A1 (en) External skin agent comprising modified clay for preventing inflammation
WO2005044807A3 (fr) Composes de benzoimidazole
WO2004089353A3 (fr) Procedes de traitement de la maladie de parkinson
EP2070509A3 (fr) L'utilisation de l'huile de Myrica gale
BR0207215A (pt) Derivados de pirazolopiriminona tendo ação de inibição de pde7
WO2006105888A3 (fr) Combinaisons d'agents actifs fongicides synergiques
EP2949644A3 (fr) Composés de tétracycline substituée
EP1776225A4 (fr) Encapsulation de nanostructures apres deposition: compositions, dispositifs et systemes integrant lesdites nanostructures
TW200724033A (en) Anthranilamide arthropodicide treatment
WO2004014893A3 (fr) Quinolones anti-microbiens, leurs compositions et utilisation
WO2005041924A3 (fr) Administration de levodopa et de carbidopa
EP1880719A3 (fr) Composition pour la prophylaxie ou le traitement des infections du système urinaire et son procédé associé
WO2010009892A3 (fr) Compositions destinées au traitement de la douleur et/ou de l'inflammation
WO2006119283A3 (fr) Compositions anti-odeurs et utilisation therapeutique associee
WO2008006895A3 (fr) Procédés et compositions destinés à améliorer l'efficacité d'anticorps thérapeutiques à l'aide d'activateurs des cellules t gamma delta
EP2772254A3 (fr) Nouveaux agents antibactériens
CY1108808T1 (el) Ενωσεις μοτιλιδης
MXPA05012901A (es) Composiciones topicas estables, claras, de claritromicina y procesos para su preparacion.
WO2006105889A3 (fr) Combinaisons d'agents actifs fongicides synergiques
UA98658C2 (uk) Циклічні депсипептиди
MY144307A (en) Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
WO2007028022A3 (fr) Nouveaux composes servant de modulateurs de p2x7 et leurs utilisations
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
WO2005117913A3 (fr) Composition pharmaceutique ozonisee et procede associe
EP1935417A4 (fr) Composition à utiliser pour la prévention d'un état hypoglycémique